XelyoMax has proven to be extremely efficient in the management of degenerative changes of the musculoskeletal system including bone, joints, muscles and ligaments.
The abstract of a recent study that has been published in Annals of the Rheumatological Diseases has concluded that allogenic L-GF(the abbreviation of the scientific name referring to XelyoMax) was well tolerated and showed encouraging results in patients with symptomatic knee osteoarthritis (KOA), regarding improvement of pain, stiffness and function in addition to decreasing knee effusion.
EVALUATING THE EFFECTIVENESS OF INTRA-ARTICULAR KNEE INJECTION USING ALLOGENIC PLATELET DERIVED LYOPHILIZED GROWTH FACTORS IN EGYPTIAN PATIENTS WITH SYMPTOMATIC PRIMARY KNEE OSTEOARTHRITIS
Rasmia Elgohary,Amany Diab,Hala Elgndy,Hossam Fahmy,Kamel Gado
Annals of Rheumatic diseases. BMJ journals. Volume 78, Issue Suppl 2
